ResearcherNational Taiwan UniversityNo recent work listed

Kuo‐Liong Chien

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4979-8351; OpenAlex author ID A5081166552. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper

Papers 2

Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. Last author DOI 10.1136/bmj.g7371 ↗
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. First author DOI 10.1016/s1470-2045(13)70388-7 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu‐Kang Tu · 2 shared papers, 2013–2015 · strength 0.10
- Paper Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. DOI 10.1136/bmj.g7371 ↗
- Paper Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. DOI 10.1016/s1470-2045(13)70388-7 ↗
Wei‐Chih Liao · 2 shared papers, 2013–2015 · strength 0.10
- Paper Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. DOI 10.1136/bmj.g7371 ↗
- Paper Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. DOI 10.1016/s1470-2045(13)70388-7 ↗
Jaw‐Town Lin · 1 shared paper, 2013 · strength 0.04
- Paper Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. DOI 10.1016/s1470-2045(13)70388-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.